The Landscape of Adoptive Cellular Therapies in Ovarian Cancer
Ovarian cancers are typically poorly immunogenic and have demonstrated disappointing responses to immune checkpoint inhibitor (ICI) therapy. Adoptive cellular therapy (ACT) offers an alternative method of harnessing the immune system that has shown promise, especially with the success of chimeric an...
Main Authors: | Lucy Davis, Rowan E Miller, Yien Ning Sophia Wong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/19/4814 |
Similar Items
-
Adoptive T cell therapy for solid tumors: current landscape and future challenges
by: Víctor Albarrán, et al.
Published: (2024-03-01) -
CRISPR–Cas9 applications in T cells and adoptive T cell therapies
by: Xiaoying Chen, et al.
Published: (2024-04-01) -
Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine
by: Jesús Fuentes-Antrás, et al.
Published: (2020-10-01) -
Adoptive Cellular Therapy for Multiple Myeloma Using CAR- and TCR-Transgenic T Cells: Response and Resistance
by: Franziska Füchsl, et al.
Published: (2022-01-01) -
CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation
by: Markus Barden, et al.
Published: (2023-02-01)